AAV‐mediated expression of wild‐type and ALS‐linked mutant VAPB selectively triggers death of motoneurons through a Ca2+‐dependent ER‐associated pathway

J. Neurochem. (2010) 114, 795–809.

[1]  V. Olkkonen,et al.  ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. , 2010, Journal of neurochemistry.

[2]  B. Pettmann,et al.  Collapsin Response Mediator Protein 4a (CRMP4a) Is Upregulated in Motoneurons of Mutant SOD1 Mice and Can Trigger Motoneuron Axonal Degeneration and Cell Death , 2010, The Journal of Neuroscience.

[3]  Hitoshi Takahashi,et al.  Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice , 2009, Neurobiology of Disease.

[4]  N. Cairns,et al.  TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration , 2009, Proceedings of the National Academy of Sciences.

[5]  G. Rouleau,et al.  Genetics of motor neuron disorders: new insights into pathogenic mechanisms , 2009, Nature Reviews Genetics.

[6]  W. Robberecht,et al.  Recent advances in motor neuron disease , 2009, Current opinion in neurology.

[7]  J. Comella,et al.  Specific vulnerability of mouse spinal cord motoneurons to membrane depolarization , 2009, Journal of neurochemistry.

[8]  P. Caroni,et al.  A role for motoneuron subtype–selective ER stress in disease manifestations of FALS mice , 2009, Nature Neuroscience.

[9]  B. Keller,et al.  Low Ca2+ buffering in hypoglossal motoneurons of mutant SOD1 (G93A) mice , 2008, Neuroscience Letters.

[10]  J. Ngsee,et al.  FFAT rescues VAPA-mediated inhibition of ER-to-Golgi transport and VAPB-mediated ER aggregation , 2008, Journal of Cell Science.

[11]  S. Lev,et al.  Coordinated lipid transfer between the endoplasmic reticulum and the Golgi complex requires the VAP proteins and is essential for Golgi-mediated transport. , 2008, Molecular biology of the cell.

[12]  Hynek Wichterle,et al.  Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons , 2008, Science.

[13]  P. Aebischer,et al.  Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  Christos G. Gkogkas,et al.  VAPB interacts with and modulates the activity of ATF6. , 2008, Human molecular genetics.

[15]  M. Horne,et al.  RETRACTED: Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis , 2008, Neurobiology of Disease.

[16]  S. Lev,et al.  The VAP protein family: from cellular functions to motor neuron disease. , 2008, Trends in cell biology.

[17]  K. Talbot,et al.  Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS , 2008, Progress in Neurobiology.

[18]  D. Gutmann,et al.  Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis , 2008, Nature Neuroscience.

[19]  M. Portero-Otín,et al.  Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. , 2007, Brain : a journal of neurology.

[20]  N. Mercuri,et al.  Altered calcium homeostasis in motor neurons following AMPA receptor but not voltage-dependent calcium channels’ activation in a genetic model of amyotrophic lateral sclerosis , 2007, Neurobiology of Disease.

[21]  Dries Braeken,et al.  Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity , 2007, Proceedings of the National Academy of Sciences.

[22]  C. Hoogenraad,et al.  Motor Neuron Disease-Associated Mutant Vesicle-Associated Membrane Protein-Associated Protein (VAP) B Recruits Wild-Type VAPs into Endoplasmic Reticulum-Derived Tubular Aggregates , 2007, The Journal of Neuroscience.

[23]  S. Salani,et al.  Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice , 2007, Annals of neurology.

[24]  Hynek Wichterle,et al.  Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons , 2007, Nature Neuroscience.

[25]  C. Svendsen,et al.  Over-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiation. , 2007, Human molecular genetics.

[26]  I. Ionov.  Survey of ALS‐associated factors potentially promoting Ca2+ overload of motor neurons , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[27]  R. Dengler,et al.  Temporospatial coupling of networked synaptic activation of AMPA-type glutamate receptor channels and calcium transients in cultured motoneurons , 2006, Neuroscience.

[28]  I. Nishimoto,et al.  Characterization of Amyotrophic Lateral Sclerosis-linked P56S Mutation of Vesicle-associated Membrane Protein-associated Protein B (VAPB/ALS8)* , 2006, Journal of Biological Chemistry.

[29]  D. Cleveland,et al.  ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors , 2006, Neuron.

[30]  F. Raynaud,et al.  Implication of calpain in neuronal apoptosis , 2006, The FEBS journal.

[31]  P. Greer,et al.  Ubiquitous Calpains Promote Caspase-12 and JNK Activation during Endoplasmic Reticulum Stress-induced Apoptosis* , 2006, Journal of Biological Chemistry.

[32]  B. Pettmann,et al.  Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Pico Caroni,et al.  Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF , 2006, Nature Neuroscience.

[34]  V. Meininger.  Clinical Trials in ALS: What Did We Learn from Recent Trials in Humans? , 2006, Neurodegenerative Diseases.

[35]  Emmanuel Brouillet,et al.  Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment , 2005, Neurobiology of Disease.

[36]  A. Al-Chalabi,et al.  A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population , 2005, Human Genetics.

[37]  B. Keller,et al.  Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS , 2005, Trends in Neurosciences.

[38]  W. Robberecht,et al.  GluR2 Deficiency Accelerates Motor Neuron Degeneration in a Mouse Model of Amyotrophic Lateral Sclerosis , 2005, Journal of neuropathology and experimental neurology.

[39]  F. Heyd,et al.  Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles. , 2005, Journal of virological methods.

[40]  C. Henderson,et al.  Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS , 2005, Nature Medicine.

[41]  L. Petrucelli,et al.  Gene dosage and pathogenesis of Parkinson's disease. , 2005, Trends in molecular medicine.

[42]  S. Lev,et al.  Differential Regulation of Endoplasmic Reticulum Structure through VAP-Nir Protein Interaction* , 2005, Journal of Biological Chemistry.

[43]  T. Gillingwater,et al.  A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. , 2004, American journal of human genetics.

[44]  J. Milbrandt,et al.  Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration , 2004, Science.

[45]  L. Barbeito,et al.  Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis , 2004, Journal of neurochemistry.

[46]  M. Kay,et al.  Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[47]  R. Kaufman,et al.  The mammalian unfolded protein response. , 2003, Annual review of biochemistry.

[48]  Hiroshi Nishimune,et al.  Motoneuron Death Triggered by a Specific Pathway Downstream of Fas Potentiation by ALS-Linked SOD1 Mutations , 2002, Neuron.

[49]  H. Wichterle,et al.  Directed Differentiation of Embryonic Stem Cells into Motor Neurons , 2002, Cell.

[50]  P. Aebischer,et al.  α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[51]  B. Keller,et al.  Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)‐related motoneurone disease , 2000, The Journal of physiology.

[52]  Z. Elazar,et al.  Erg30, a Vap-33–Related Protein, Functions in Protein Transport Mediated by Copi Vesicles , 1999, The Journal of cell biology.

[53]  Vincent C. Emery,et al.  J. Virol. Methods , 1996 .

[54]  J. E. Vaughn,et al.  Differential Vulnerability of Two Subsets of Spinal Motor Neurons in Amyotrophic Lateral Sclerosis , 1996, Experimental Neurology.

[55]  D. Housman,et al.  The peripheral myelin gene PMP–22/GAS–3 is duplicated in Charcot–Marie–Tooth disease type 1A , 1992, Nature Genetics.

[56]  I. Nishimoto,et al.  1 Characterization of Amyotrophic Lateral Sclerosis-Linked Pro 56 Ser Mutation of Vesicle-Associated Membrane Protein-Associated Protein B ( VAPB / ALS 8 ) , 2006 .

[57]  D. Campion,et al.  APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy , 2006, Nature Genetics.

[58]  Kai Long,et al.  A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. , 2005, Science.

[59]  Ya-min Wu,et al.  Directed differentiation of embryonic stem cells into motor neurons by gene , 2004 .

[60]  J. Ridet,et al.  alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[61]  B. Pettmann,et al.  Cardiotrophin‐1 requires LIFRβ to promote survival of mouse motoneurons purified by a novel technique , 1999, Journal of neuroscience research.